Literature DB >> 24465101

Acute biliary pancreatitis: an experience in a tertiary level hospital of Nepal.

Sujan Manandhar1, Smith Giri1, Prakash Poudel1, Ramesh Singh Bhandari1, Paleswan Joshi Lakhey1, Pradeep Vaidya1.   

Abstract

Acute Biliary Pancreatitis is one of the commonest forms of pancreatitis in Nepal. Controversies exist as to the most appropriate way of management of these cases. The present study was carried out to evaluate the management and outcome of Acute Biliary Pancreatitis cases in a tertiary level hospital of Nepal. A retrospective analysis of the patients managed with Acute Biliary Pancreatits was done. All patients admitted with the diagnosis of Acute Biliary Pancreatitis over a period of 2 years were included in the study. The variables measured were age, sex, clinical presentation, laboratory investigations, mode of treatment and outcome. A total of 45 cases had Acute Biliary Pancreatitis suggesting a prevalence of 28 %. The mean age was 45 ± 10 year. 39 patients (86.6 %) were treated with conservative management. 23 patients (54 %) had an uneventful recovery without any complications. 21 patients (46 %) developed some form of complications but recovered successfully. Mortality was seen in only one patient in the conservatively treated group. In a resource poor setting such as Nepal, definitive management is not always possible. Conservative management of Acute Biliary Pancreatitis has a favorable outcome in the majority of our patients with acceptable morbidity and mortality. Definitive management can be safely performed during index admission where possible.

Entities:  

Keywords:  Acute pancreatitis; Biliary; Conservative management; Outcome

Year:  2012        PMID: 24465101      PMCID: PMC3900759          DOI: 10.1007/s12262-012-0533-5

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  22 in total

1.  Predicting severe pancreatitis.

Authors:  F Abu-Zidan
Journal:  Arch Surg       Date:  2001-10

2.  Influence of duration of symptoms over perioperative outcomes during emergency laparoscopic cholecystectomy.

Authors:  S K Sharma; P B Thapa; D K Maharjan; A Dhakal; N Baral
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2009 Apr-Jun

Review 3.  Acute gallstone pancreatitis: timing of laparoscopic cholecystectomy in mild and severe disease.

Authors:  W Uhl; C A Müller; L Krähenbühl; S W Schmid; S Schölzel; M W Büchler
Journal:  Surg Endosc       Date:  1999-11       Impact factor: 4.584

4.  Diagnostic assays in acute pancreatitis. A study of sensitivity and specificity.

Authors:  W M Steinberg; S S Goldstein; N D Davis; J Shamma'a; K Anderson
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

Review 5.  Management of acute pancreatitis in emergency.

Authors:  V Ojetti; A Migneco; A Manno; A Verbo; G Rizzo; N Gentiloni Silveri
Journal:  Eur Rev Med Pharmacol Sci       Date:  2005 Mar-Apr       Impact factor: 3.507

Review 6.  Pancreatitis.

Authors:  R M S Mitchell; M F Byrne; J Baillie
Journal:  Lancet       Date:  2003-04-26       Impact factor: 79.321

7.  The urgent diagnosis of gallstones in acute pancreatitis: a prospective study of three methods.

Authors:  J P Neoptolemos; A W Hall; D F Finlay; J M Berry; D L Carr-Locke; D P Fossard
Journal:  Br J Surg       Date:  1984-03       Impact factor: 6.939

8.  Predicting gallstone pancreatitis with laboratory parameters: a meta-analysis.

Authors:  S Tenner; H Dubner; W Steinberg
Journal:  Am J Gastroenterol       Date:  1994-10       Impact factor: 10.864

9.  Management guidelines for gallstone pancreatitis. Are the targets achievable?

Authors:  Pandanaboyana Sanjay; Sim Yeeting; Carole Whigham; Hannah K Judson; Christoph Kulli; Francesco M Polignano; Iain S Tait
Journal:  JOP       Date:  2009-01-08

10.  Acute gallstone pancreatitis: a constant challenge for the surgeon.

Authors:  T S Papavramidis; N Zandes; K Hatzimisios; Th Koutsimani; F Kehagia; P Agorastou; M Doulgerakis; I Patoulidis
Journal:  Indian J Surg       Date:  2008-11-26       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.